In Case of a Shortage: Strategies to Conserve the Immune Globulin Supply
What can be done in the event of a severe shortage of IG products, whose production is entirely reliant on a continuous supply of IgG-rich plasma donated at more than 800 dedicated U.S. collection facilities?
Tackling Sepsis in Hospitals
By raising awareness and developing tools to detect sepsis earlier, healthcare organizations save lives from this often-deadly infection.
Myths & Facts: Antibiotics
To staunch the growing threat of antibiotic resistance, the medical profession is pivotal in properly prescribing antibiotics and educating patients about their appropriate use.
Importing Drugs: Is It Safe and Responsible?
As Americans continue to grapple with the skyrocketing costs of prescription drugs, many are turning to other countries to access medications they need at prices they can afford.
Long-Term Effects of COVID-19
Long-haul COVID, now termed PASC, is a very real effect of the SARs-CoV-2 virus, but few physicians are familiar with the symptoms and where to send patients for treatment.
Pandemic Preparedness: Ensuring the U.S. Is Ready for the Next One?
After several federal agencies spent two decades and tens of billions of dollars preparing for the next pandemic, critics were not shy about pointing out how unprepared the United States was for the current SARS-Cov-2 pandemic.
Myths & Facts: Alzheimer’s Disease
Government and researchers continue to pursue plans and studies to gain a greater understanding of this devastating and deadly disease to prevent, treat and, ultimately, cure it.
The Promise of COVID-19 Hyperimmune Immune Globulin Therapy
As of this writing, NIAID and industry collaborators are also finalizing the design of a large-scale trial to assess whether COVID-Ig can reduce the rate of hospitalization and other medical encounters in earlier-stage COVID-19 patients exhibiting mild to moderate symptoms.
Plasma Therapies: Effective COVID-19 Treatments?
Studies shed light on whether high-dose intravenous immune globulin, convalescent plasma and hyperimmune globulin will be effective therapeutic options for the novel coronavirus.
No Place Like Home: The Growing Acceptance of Subcutaneous Immune Globulin
Is SCIG well-accepted by most patients either previously treated with IVIG or just starting out on IG therapy?